ATE213945T1 - Verwendung von olanzapin zur herstellung eines arzneimittels zur neuroprotektion - Google Patents
Verwendung von olanzapin zur herstellung eines arzneimittels zur neuroprotektionInfo
- Publication number
- ATE213945T1 ATE213945T1 AT98302789T AT98302789T ATE213945T1 AT E213945 T1 ATE213945 T1 AT E213945T1 AT 98302789 T AT98302789 T AT 98302789T AT 98302789 T AT98302789 T AT 98302789T AT E213945 T1 ATE213945 T1 AT E213945T1
- Authority
- AT
- Austria
- Prior art keywords
- olanzapine
- neuroprotection
- production
- medicinal product
- neuro
- Prior art date
Links
- KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 title abstract 2
- 229960005017 olanzapine Drugs 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 230000004112 neuroprotection Effects 0.000 title 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4309497P | 1997-04-15 | 1997-04-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE213945T1 true ATE213945T1 (de) | 2002-03-15 |
Family
ID=21925472
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98302789T ATE213945T1 (de) | 1997-04-15 | 1998-04-09 | Verwendung von olanzapin zur herstellung eines arzneimittels zur neuroprotektion |
| AT01202986T ATE260662T1 (de) | 1997-04-15 | 1998-04-09 | Verwendung von olanzapin zur herstellung eines arzneimittels zur neuroprotektion |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01202986T ATE260662T1 (de) | 1997-04-15 | 1998-04-09 | Verwendung von olanzapin zur herstellung eines arzneimittels zur neuroprotektion |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0872238B1 (de) |
| AT (2) | ATE213945T1 (de) |
| AU (1) | AU6955998A (de) |
| DE (2) | DE69822234T2 (de) |
| DK (1) | DK0872238T3 (de) |
| ES (2) | ES2173550T3 (de) |
| PT (2) | PT872238E (de) |
| WO (1) | WO1998046596A1 (de) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5229382A (en) * | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
| US5627178A (en) * | 1991-04-23 | 1997-05-06 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
| US5605897A (en) * | 1991-04-23 | 1997-02-25 | Eli Lilly And Company | 2-methyl-thieno-benzodiazepine |
| US5457101A (en) * | 1994-06-03 | 1995-10-10 | Eli Lilly And Company | Thieno[1,5]benzoidiazepine use |
| US5536718A (en) * | 1995-01-17 | 1996-07-16 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
| US5637584A (en) * | 1995-03-24 | 1997-06-10 | Eli Lilly And Company | Solvate of olanzapine |
| EG23659A (en) * | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
| US5631250A (en) * | 1995-03-24 | 1997-05-20 | Eli Lilly And Company | Process and solvate of 2-methyl-thieno-benzodiazepine |
| US5696115A (en) * | 1995-04-21 | 1997-12-09 | Eli Lilly And Company | Method for treating nicotine withdrawal |
| US5744470A (en) * | 1996-03-11 | 1998-04-28 | Eli Lilly And Company | Method for treating insomnia |
| US5744469A (en) * | 1996-11-26 | 1998-04-28 | Eli Lilly And Company | Method for treating dermatitis |
-
1998
- 1998-04-08 WO PCT/US1998/006932 patent/WO1998046596A1/en not_active Ceased
- 1998-04-08 AU AU69559/98A patent/AU6955998A/en not_active Abandoned
- 1998-04-09 ES ES98302789T patent/ES2173550T3/es not_active Expired - Lifetime
- 1998-04-09 PT PT98302789T patent/PT872238E/pt unknown
- 1998-04-09 AT AT98302789T patent/ATE213945T1/de not_active IP Right Cessation
- 1998-04-09 PT PT01202986T patent/PT1155696E/pt unknown
- 1998-04-09 ES ES01202986T patent/ES2215851T3/es not_active Expired - Lifetime
- 1998-04-09 DK DK98302789T patent/DK0872238T3/da active
- 1998-04-09 DE DE69822234T patent/DE69822234T2/de not_active Expired - Fee Related
- 1998-04-09 DE DE69804034T patent/DE69804034T2/de not_active Expired - Fee Related
- 1998-04-09 EP EP98302789A patent/EP0872238B1/de not_active Expired - Lifetime
- 1998-04-09 AT AT01202986T patent/ATE260662T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0872238A2 (de) | 1998-10-21 |
| DE69804034T2 (de) | 2002-10-17 |
| DK0872238T3 (da) | 2002-06-24 |
| WO1998046596A1 (en) | 1998-10-22 |
| ATE260662T1 (de) | 2004-03-15 |
| EP0872238A3 (de) | 1998-10-28 |
| PT872238E (pt) | 2002-07-31 |
| AU6955998A (en) | 1998-11-11 |
| DE69804034D1 (de) | 2002-04-11 |
| PT1155696E (pt) | 2004-06-30 |
| DE69822234D1 (de) | 2004-04-08 |
| DE69822234T2 (de) | 2005-02-24 |
| ES2215851T3 (es) | 2004-10-16 |
| ES2173550T3 (es) | 2002-10-16 |
| EP0872238B1 (de) | 2002-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69204639D1 (de) | Verwendung von Modafinil zur Herstellung eines antiischämischen Arzneimittels. | |
| ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
| DE69435330D1 (de) | Verwendung von Botulinumtoxin Typ B zur Herstellung eines Medikaments zur Behandlung von Muskelkrämpfen | |
| ATE306931T1 (de) | Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer | |
| FI923548A7 (fi) | Vaahtoa muodostava koostumus farmaseuttiseen käyttöön, sen käyttö ja h oitomenetelmä | |
| ATE269077T1 (de) | Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen | |
| ATE137965T1 (de) | Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege | |
| FI973040L (fi) | Rasemointimenetelmä käytettäväksi levobupivakaiinin ja siihen läheisesti liittyvien piperidiinikarboksanilidipuudutusaineiden valmistuksessa | |
| IL114296A (en) | Use of melatonin in the manufacture of medicament for treating or preventing addiction to benzodiazepines pharmaceutical formulation for this purpose and process for making the formulation | |
| PL338673A1 (en) | Application of fanquinone in treating alzheimer disease | |
| NO944339L (no) | Melatoninderivater for anvendelse ved behandling av sövnforstyrrelser | |
| DE59611383D1 (de) | Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben | |
| ATA901396A (de) | Verwendung von melatonin zur behandlung von an medikamentensucht leidenden patienten | |
| ATE136465T1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
| ATE260662T1 (de) | Verwendung von olanzapin zur herstellung eines arzneimittels zur neuroprotektion | |
| ATE201993T1 (de) | Verwendung von olanzapine zur herstellung eines arzneimittels zur behandlung der zerebralen fokalen ischämie | |
| NO984196D0 (no) | Fremgangsmåte for behandling av stoffmisbruk | |
| ITMI941939A0 (it) | Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |